Today: 29 April 2026
Browse Category

NASDAQ:SOPA 27 December 2025 - 30 December 2025

Society Pass (SOPA) stock jumps 61% after TikTok Shop live-commerce launch in Thailand

Society Pass (SOPA) stock jumps 61% after TikTok Shop live-commerce launch in Thailand

Society Pass shares soared 61% to $2.93 on volume of 153 million after launching a TikTok Shop live-commerce platform in Thailand. The stock traded between $2.21 and $3.46, far above typical activity. Executives set a $10 million revenue target for the new business line in 2026. Traders are watching for early traction and updates on earnings.
30 December 2025
···
Society Pass stock jumps on Thailand TikTok Shop live-commerce launch

Society Pass stock jumps on Thailand TikTok Shop live-commerce launch

Society Pass shares rose 34% to $2.43 by early afternoon after launching a live-commerce platform in Thailand through its Thoughtful Media Group. Trading volume topped 127 million shares. The company set a $10 million revenue target for 2026 and referenced a $90 billion Southeast Asian social-commerce market. Investors await traction data and updates on a pending share registration.
29 December 2025
·
Society Pass Incorporated Stock (NASDAQ: SOPA) Surges 58% as New Analyst Targets Spotlight NusaTrip and AI Pivot — What Investors Should Watch Next

Society Pass Incorporated Stock (NASDAQ: SOPA) Surges 58% as New Analyst Targets Spotlight NusaTrip and AI Pivot — What Investors Should Watch Next

Society Pass (NASDAQ: SOPA) surged 58% Friday to close near $1.82, with tens of millions of shares traded—far exceeding its 6.1 million share count. The spike followed a bullish research note from Greenridge Global and came amid thin, post-holiday trading. Major indexes eased after a brief rally. SOPA heads into Monday’s open with heightened volatility and attention.
27 December 2025
···

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
The Dow Jones Industrial Average dropped 320 points, or 0.65%, to 48,821.82 Wednesday afternoon, heading for a fifth straight loss as investors awaited the Federal Reserve’s rate decision and major tech earnings. Brent crude surged 7.14% to $119.20 after reports of a possible extended Iran blockade. Boeing and Goldman Sachs weighed on the Dow, while Amazon rose and Microsoft slipped in midday trading.
General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Go toTop